QDDresearch

Albertsons Companies, Inc. ACI

Consumer StaplesFood & Drug RetailingUnited States of America

Last close 13.08 USD on Nov 1, 2026, −20.2% year to date

Quant rating

Quant rating C Rank 72 of 124 in Consumer Staples
  1. Growth C 78 of 124
  2. Valuation B 37 of 124
  3. Quality B 43 of 124
  4. Revisions D 90 of 124
  5. Momentum C 75 of 124

Wall Street consensus Hold (2.90)Average target 13.27 USD +1.4%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability fiscal year ends February 28

Growth and profitability by fiscal year
202620252024202320225Y avg
Revenue (mil)83,17280,39179,23877,65071,887–
Revenue growth3.5%1.5%2.0%8.0%3.2%3.6%
EPS (basic, normalized)2.182.342.883.373.07–
EPS growth−6.8%−18.8%−14.5%9.8%––
Gross margin27.2%27.7%27.8%28.0%28.8%27.9%
Net margin0.3%1.1%1.6%1.6%1.8%1.3%
ROE8.3%28.6%58.9%50.8%44.8%38.3%
Balance sheet, last quarter
Cash & short-term investments (mil)291
Current ratio0.82x
Long-term debt (mil)8,446
Net debt (mil)9,038
Total equity (mil)1,433
Net debt / equity6.31x
Net debt / EBITDA2.32x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2026 actual 83,172+3.5%0.2x 3,902−1.9%3.9x 2.18−6.8%6.0x
2027 81,975−1.4%0.2x 3,522−9.7%4.3x 1.73−20.6%7.6x
2028 82,303+0.4%0.2x 3,496−0.7%4.3x 1.66−4.2%7.9x
2029 82,747+0.5%0.2x 3,467−0.8%4.4x 1.71+3.3%7.6x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
202781,9750.0%0.0%−0.7%1.73−2.8%−2.6%−24.7%
202882,303−0.2%−0.2%−1.6%1.66−9.8%−9.4%−32.5%
202982,747−0.4%−0.5%−2.6%1.71−9.2%−13.1%−35.7%

Earnings surprises EPS beat in 3 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter endedMay 2024Aug 2024Nov 2024Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026Aug 2026
Sales reported (mil)24,26518,55218,77418,80024,88118,91619,12420,25224,94218,895
Sales mean (mil)24,14018,48318,82018,78524,73118,89819,16920,46824,82218,867
Surprise+0.5%+0.4%−0.2%+0.1%+0.6%+0.1%−0.2%−1.1%+0.5%+0.1%
EPS reported0.660.510.710.460.550.440.720.480.420.36
EPS mean0.670.480.660.400.530.400.680.430.540.33
Surprise−0.9%+6.4%+8.2%+13.6%+3.2%+10.1%+6.2%+11.5%−22.3%+10.0%

Peer comparison Food & Drug Retailing

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
ACI Albertsons Companies, Inc.6.2B2.32x0.3%4.35x7.6x7.9x4.3x4.3x
WMT Walmart Inc.979.9B1.16x3.1%9.99x42.9x38.3x20.9x19.3x
SYY Sysco Corporation40.8B2.67x2.1%14.88x16.4x15.4x10.9x10.4x
KR Kroger Co39.4B1.86x0.7%6.81x12.9x12.2x6.7x6.6x
CASY Caseys General Stores Inc25.1B1.29x4.1%6.14x31.8x29.0x16.6x15.3x
USFD US Foods Holding Corp.22.4B2.77x1.7%5.24x21.7x18.7x13.2x12.0x
Mean2.01x2.0%7.90x22.2x20.2x12.1x11.3x
Median2.09x1.9%6.48x19.1x17.0x12.0x11.2x

Technical analysis

  • 1M+13.7%
  • 3M+14.3%
  • 1Y−25.8%
  • 3Y−33.1%

Financial statements in millions of USD

Income statement, Albertsons Companies, Inc., fiscal years, most recent first
202620252024202320222021
Total revenue83,17280,39179,23877,65071,88769,690
Cost of revenue60,56958,13557,19255,89451,16549,276
Gross profit22,60322,25622,04621,75620,72220,414
Selling, general & administrative expenses19,03618,56318,05617,75516,78417,472
Research & development––––––
Depreciation/amortization1,7591,6841,6591,6951,5171,364
Interest expense (income), operating–−0.1−1.0–––
Unusual expense (income)1,054462263−1.9−11.346.5
Other operating expenses000000
Operating income7541,5462,0692,3072,4331,532
Net interest income (expense)−504−460−492−405−482−538
Gain (loss) on sale of assets––––––
Other non-operating income (expense)17.543.412.233.0148135
Net income before taxes2681,1301,5891,9362,1001,129
Provision for taxes50.4252293422480278
Minority interest––––––
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items2178781,2961,5141,620850
Extraordinary items–81.0–––0
Net income2179591,2961,5141,620850
EBIT, normalized1,8092,0082,3312,4062,5451,771
EBITDA, normalized3,5953,7004,1104,2134,2263,293
Basic EPS, normalized2.182.342.883.373.07–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.